| 【英語論文】 |
| |
原著論文 |
| |
1 |
Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y. Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study. Melanoma Res. 2025 Feb 1;35(1):67-74. |
| |
2 |
Yoshikawa S, Maeda C, Iizuka A, Ikeya T, Yamashita K, Ashizawa T, Kanematsu A, Miyata H, Kikuchi Y, Urakami K, Ohshima K, Nagashima T, Yamaguchi K, Kiyohara Y, Akiyama Y. Characterization of the Neoantigen Profile in a Tumor Mutation Burden-high Melanoma Patient With Multiple Metastases. Cancer Genomics Proteomics. 2025 May-Jun;22(3):496-509. |
| |
3 |
Horisaki K, Yoshikawa S, Mori S, Omata W, Tsutsumida A, Kiyohara Y. Prognostic value of the CONUT score with immune checkpoint inhibitors as first-line therapy for metastatic malignant melanoma. J Dermatol. 2025 Apr;52(4):615-623. |
| |
4 |
Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y. Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective study. J Dermatol. 2025 Apr;52(4):651-662. |
| |
5 |
Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y. Predictors of Dermal Invasion and Sentinel Lymph Node Metastasis in Patients With Extramammary Paget’s Disease Without Clinical Lymph Node Enlargement. J Dermatol. 2025 May 23. doi: 10.1111/1346-8138. |
| |
6 |
Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y. Comparison of the efficacy of rechallenge with anti-PD-1 antibody monotherapy and BRAF/MEK inhibitor in advanced malignant melanoma: A single-center, retrospective cohort study. Dermatologica Sinica 43(2):p 134-137, Apr–Jun 2025. |
